Universal flu vaccine shows promise
June 8th, 2011 - 1:42 pm ICT by IANSWashington, June 8 (IANS) A universal flu vaccine targeting a protein common to all strains of influenza A has safely produced an immune response in humans. If proven effective, the vaccine could eliminate the practice of creating a new flu vaccine annually to match predicted strains, with major implications for global health.
The results of clinical trials led by the University of Texas Medical Branch (UTMB), Galveston, with biotech company VaxInnate were funded by $9.5 million grant from the Bill and Melinda Gates Foundation, the journal Vaccine reports.
The vaccine candidate, VAX102, targets a protein known as M2e, found on the surface of the influenza A virus, that has remained relatively unchanged over the last century, according to a Texas statement.
The M2e antigen had been completely unchanged from 1918 until the recent pandemic, making it of interest to researchers searching for a target for the immune response to flu that would be stable over many seasons.
Unlike traditional flu vaccines, which target antigens that change continuously, the prototype VAX102 represents a vaccine that would not require annual updates, an important barrier to flu prevention worldwide.
The technology used to produce the candidate vaccine would eliminate many of the limitations of current flu vaccines, including limited production capability and the inability to change the target antigen should the vaccine not match the circulating strains.
“As we saw in the 2009 influenza pandemic, there is a great public and global health need for a rapid, scalable model for vaccine production,” said lead author Christine B. Turley, paediatrician and member of UTMB’s Sealy Centre for Vaccine Development.
“If ultimately proven effective, VAX102 will meet this need and offer a completely new approach to global flu prevention and control.”
- First trial to test new vaccine against multiple influenza strains successful - Aug 22, 2008
- Swine flu vaccine may be available in India this year - Jan 12, 2010
- Scientists find new method to develop flu vaccine tool - Dec 07, 2010
- One-time jab to protect against all flu strains - Nov 16, 2010
- Universal influenza vaccine 'on the anvil' - Dec 07, 2010
- Novel approach shows great potential in reducing mortality from flu - Apr 23, 2011
- H1N1 pandemic flu strain 'key to universal vaccine' - Jan 11, 2011
- 'Immune evasion' uncommon in M. tuberculosis - May 24, 2010
- Now, a universal vaccine that kills all strains of flu virus - Feb 07, 2011
- Progress made toward universal flu vaccine - May 20, 2010
- Swine flu claims 10 victims in Britain - Dec 13, 2010
- Scientists review fate of pandemic H1N1 flu virus - Sep 29, 2010
- Mutation that could allow H1N1 to spread much more easily identified - Mar 10, 2011
- Now, a 'universal' vaccine that could fend off all types of flu - Jul 16, 2010
- New compound destroys deadly flu virus - Sep 26, 2011
Tags: bill and melinda gates, bill and melinda gates foundation, biotech company, candidate vaccine, flu prevention, flu vaccine, flu vaccines, health need, influenza a virus, influenza pandemic, melinda gates foundation, production capability, scalable model, target antigen, texas medical branch, university of texas medical branch, utmb galveston, vaccine candidate, vaccine production, vaxinnate